OXY Debt Reduction Gains Traction, but Buyback Shift Remains Key

What happened

Occidental's aggressive debt reduction following the OxyChem sale is gaining market attention, lowering interest expenses and improving balance sheet flexibility. The company has reduced principal debt to $15.0B, targeting sustainable cash flow allocation between debt paydown and shareholder returns. However, with realized crude prices near $59/bbl and production guidance flat, the equity catalyst hinges on restarting buybacks, not just debt cuts. While management raised the dividend and executed tender offers to remove covenants, cash returns to shareholders absent buybacks remain yield-only. The next 6-12 months will test whether stable volumes and lower capex can generate enough free cash flow to support meaningful repurchases.

Implication

Investors should watch for quarterly updates on share repurchases and production efficiency. If OXY maintains ~1.45 MMboe/d on $5.5-5.9B capex and begins buybacks, the stock could re-rate toward $62-65. However, if buybacks remain absent and retained OxyChem liabilities surface, the bear case of $48 becomes more likely. The balance sheet improvement provides downside protection, but upside requires management to shift from debt-first to shareholder return mode.

Thesis delta

The narrative shift is from 'debt reduction as a cleanup' to 'debt reduction as a base for shareholder returns.' The key change is that the market now expects not just lower leverage but tangible buybacks. If buybacks materialize, the stock can exit the 'Buffett premium' and trade on its own merits.